Clonidine in the management of asymmetrical gustatory facial sweating: an N-of-1 trial.
To determine the efficacy of clonidine in the management of gustatory facial sweating (GFS) ipsilateral to an upper thoracic sympathectomy. Placebo-controlled N-of-1 trial. Tertiary care referral center. Clonidine patch that delivers 0.2mg/d. Daily episodes of GFS are recorded. The severity of GFS is graded as mild, moderate, or severe, and a daily GFS score is calculated. Clonidine was shown to significantly decrease (p < .05) the incidence and frequency of gustatory facial sweating.